IL6 and adenocarcinoma: Although, no statistically significant changes in IL-6 and TNF-α levels are found between any group of lung cancer patients (adenocarcinoma, SqCC, other NSCLC, and other neoplasms than NSCLC), there are slightly higher levels of IL-6 in SqCC patients.